CL 218872
| Title | Journal |
|---|---|
| Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse. | Bioorganic & medicinal chemistry 20101101 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination. | The Journal of pharmacology and experimental therapeutics 20060301 |
| Pharmacological properties of GABAA receptors containing gamma1 subunits. | Molecular pharmacology 20060201 |
| Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors. | Psychopharmacology 20060101 |
| Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit. | Journal of medicinal chemistry 20050310 |
| 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1. | Journal of medicinal chemistry 20040325 |
| Spatial learning deficits induced by muscimol and CL218,872: lack of effect of prenatal malnutrition. | Nutritional neuroscience 20031201 |
| Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors. | Psychopharmacology 20030101 |
| Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors. | European journal of pharmacology 20020215 |
| Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor. | Journal of neurochemistry 20010401 |
| Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. | Journal of medicinal chemistry 20000113 |
| Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors. | Journal of medicinal chemistry 19980702 |
| Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors. | Molecular pharmacology 19960201 |
| Expression and pharmacology of human GABAA receptors containing gamma 3 subunits. | European journal of pharmacology 19951130 |
| Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. | Journal of medicinal chemistry 19941223 |
| Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. | Science (New York, N.Y.) 19890922 |
| The benzodiazepine receptor ligand CL218,872 has both anxiolytic and sedative properties in rodents. | Neuropharmacology 19840701 |